1,276
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Comparing treatment adherence of lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: a retrospective analysis

, , , , , & show all
Pages 962-975 | Accepted 18 Apr 2013, Published online: 07 Jun 2013

References

  • Verma R, Balhara YP, Mathur S. Management of attention-deficit hyperactivity disorder. J Pediatr Neurosci 2011;6:13-18
  • Wolraich ML. Attention-deficit hyperactivity disorder. Semin Pediatr Neurol 2006;13:279-85
  • Barkley R, Fischer M, Smallish L, et al. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol 2002;111:279-89
  • Bloom B, Cohen RA. Summary Health Statistics for U.S. Children: National Health Interview Survey, 2006. National Center for Health Statistics. Vital Health Stat 2007;10:1-79
  • Kinbami L, Xiang L, Pastor P, et al. Attention Deficit Hyperactivity Disorder among children aged 5-17 years in the United States, Hyattsville, MD: National Center for Health Statistics. 1998-2009, NCHS Data Brief, No.70. 2011
  • Kessler CR, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 2006;163:716-23
  • National Institute for Health and Clinical Excellence. Attention deficit hyperactivity disorder: The NICE Guideline on diagnosis and management of ADHD in children, young people and adults. Leicester (UK): British Psychological Society (UK). 2009, National Clinical Practice Guideline 72
  • Shaw M, Hodgkins P, Caci H, et al. A systematic review and analysis of long-term outcomes in ADHD: effects of treatment and non-treatment. BMC Med 2012;10:99
  • Spencer TJ. ADHD and comorbidity in childhood. J Clin Psychiatry 2006;67(8 Suppl):27-31
  • Goldman L, Genel M, Bezman R, et al. Diagnosis and treatment of Attention-Deficit/Hyperactivity Disorder in children and adolescents. JAMA 1998;279:1100-7
  • Cussen A, Sciberras E, Ukoumunne O, et al. Relationship between symptoms of attention-deficit/hyperactivity disorder and family functioning: a community-based study. Eur J Pediatr 2012;171:271-80
  • Canadian ADHD Resource Alliance. Canadian ADHD Practice Guidelines (CAP-Guidelines). 3rd edn. Toronto ON; CADDRA. 2011, p 158
  • GroupHealth. Attention deficit hyperactivity disorder (ADHD): Adults – Diagnosis and treatment guideline. Group Health Cooperative. Seattle, WA. 2011, p 15
  • Olfson M, Gameroff M, Marcus S, et al. National trends in the treatment of attention deficit hyperactivity disorder. Am J Psychiatry 2003;160:1071-7
  • Christensen L, Sasané R, Hodgkins P, et al. Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population. Curr Med Res Opin 2010;26:977-89
  • American Academy of Pediatrics. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics 2011;128:2011-654
  • Weiss M, Murray C. Assessment and management of attention-deficit hyperactivity disorder in adults. Can Med Ass J 2003;168:715-22
  • Seixas M, Weiss M, M�U. Systematic review of national and international guidelines on attention-deficit hyperactivity disorder. J Psychopharmacol. 2012;26:753-65
  • Elia J, Ambrosini PJ, Rapoport JL. Treatment of attention-deficit-hyperactivity disorder. N Engl J Med 1999;340:780-8
  • Jensen P, Arnold E, Severe J, et al. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry 1999;56:1073-86
  • Hodgkins P, Shaw M, Coghill D, et al. Amfetamine and methylphenidate medications for ADHD: complementary treatment options. Eur Child Adol Psych 2012;21:477-92
  • Adler LD, Nierenberg AA. Review of medication adherence in children and adults with ADHD. Postgrad Med 2010;122:184-91
  • Cascade E, Kalali AH, Weisler RH, et al. Seasonality and the changing adult/child prescription ratios in ADHD Therapy. Psychiatry (Edgmont) 2008;5:23-5
  • Safren SA, Duran P, Yovel I, et al. Medication adherence in psychopharmacologically treated adults with ADHD. J Atten Disord 2007;10:257-60
  • World Health Organization. Adherence to long-term therapies: evidence for action. Geneva, Switzerland: World Health Organization, 2003. p 19-26
  • Elliot RA, Barber N, Horne R. Cost-effectiveness of adherence-enhancing interventions: a quality assessment of the evidence. Ann Pharmacother 2005;39:508-15
  • Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Medical Care 2005;43:1130-9
  • Elixhauser A, Steiner C, Kruzikas D. Comorbidity Software Documentation. 2004. HCUP Methods Series Report # 2004-1. ONLINE February 6, 2004. U.S. Agency for Healthcare Research and Quality. Available: http://www.hcupus.ahrq.gov/toolssoftware/comorbidity/comorbidity.jsp.
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition [DSM-IV], 1994
  • Choudhry NK, Shrank WH, Levin RL, et al. Measuring concurrent adherence to multiple related medications. Am J Managed Care 2009;15:457-64
  • Yeaw J, Benner JS, Walt JG, et al. Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm 2009;15:728-40
  • Peterson AM, Nau DP, Cramer JA, et al. A checklist for medication compliance and persistence studies using retrospective databases. Value Health 2007;10:3-12
  • Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6:65-70
  • Hodgkins P, Sasané R, Meijer WM. Pharmacologic treatment of Attention-Deficit/Hyperactivity Disorder in children: incidence, prevalence, and treatment patterns in the Netherlands. Clin Therapeut 2011;33:188-203
  • Setyawan J, Hodgkins P, Guerin A, et al. Comparison of treatment persistency in patients initiated on of Lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: a retrospective analysis (In Process Citation)
  • Dreyer S, O’Laughlin L. Parental adherence to clinical recommendations in an ADHD evaluation clinic. J Clin Psychol 2010;66:1101-20
  • Faraone S, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow up studies. Psychol Med 2006;36:159-65

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.